Virmedex Wins the 15th Research Valuation Award from the UPC Social Council
The award recognizes the successful technology transfer born in the research laboratories of the TecSalut group.
Barcelona, Spain //
The Social Council of the Universitat Politècnica de Catalunya (UPC) has awarded Virmedex first prize in the 15th edition of the Research Valuation Awards under the “Best Technology-Based Company” category.
The jury highlighted Virmedex’s achievement in translating over twenty years of academic research from the TecSalut group into a highly scalable, SaaS business model with an active commercial presence in competitive international markets, including the United States. Read more (Spanish)
More news
Hofstra University integrates AI-driven VR simulation into Perfusion Medicine curriculum
Hofstra University’s Master of Science in Cardiovascular Sciences & Perfusion Medicine program officially introduces AI-driven VR perfusion training to advance student mastery of extracorporeal loops and emergency protocols.
Read the article →
The Catalan startup Virmedex is launching its second video game designed to train users in medical procedures
With support from ACCIÓ through its Startup Capital program (€100,000), the spin-off is launching virECMO, a virtual reality simulator designed to train healthcare professionals in extracorporeal membrane oxygenation.
Read the article →
Virmedex Beneficiary of the European Women TechEU Cohort
Virmedex is officially selected as a winner of the highly competitive EU-funded Women TechEU initiative. The program awards CEO Dani Tost a non-dilutive scale-up grant and high-level mentorship celebrating women trailblazers in deep-tech.
Read the article →